Aphria Inc. Class Action
March 26, 2019
This class action concerns allegations that Aphria Inc.’s public filings contained false and misleading statements about its business and affairs. It is alleged that Aphria failed to disclose material facts about its acquisition of LATAM Holdings Inc., that Aphria had improper disclosure controls and procedures, and that Aphria insiders inappropriately
August 25, 2017
This class action concerns allegations that the public filings of Sino-Forest Corporation (“Sino-Forest”) contained false and/or misleading statements about its business and affairs. It is alleged that Sino-Forest falsely maintained that its financial statements complied with Canadian generally accepted accounting principles (GAAP) and it materially overstated the size and value
Valeant Pharmaceuticals International, Inc.
February 26, 2018
This is a class action against Valeant Pharmaceuticals International, Inc., its officers and directors, auditor, and underwriters which alleges that the company and certain of the company’s senior officers failed to disclose Valeant’s relationship with Philidor Rx Services LLC. If you acquired Valeant securities, including shares or notes, between February